Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery

[1]  D. Lobo,et al.  ESPEN guideline: Clinical nutrition in surgery. , 2017, Clinical nutrition.

[2]  I. Yano,et al.  Efficacy of protocol‐based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery , 2017, Journal of clinical pharmacy and therapeutics.

[3]  J. Romijn,et al.  Effect of Short-Term Fasting on Systemic Cytochrome P450-Mediated Drug Metabolism in Healthy Subjects: A Randomized, Controlled, Crossover Study Using a Cocktail Approach , 2017, Clinical Pharmacokinetics.

[4]  Takeshi Kimura,et al.  Effect of vitamin K2 on the anticoagulant activity of warfarin during the perioperative period of catheter ablation: Population analysis of retrospective clinical data , 2016, Journal of pharmaceutical health care and sciences.

[5]  Ferruh Elbir,et al.  The effects of Ramadan fasting on patients with prosthetic heart valve taking warfarin for anticoagulation , 2016, Journal of the Saudi Heart Association.

[6]  J. Romijn,et al.  Short-Term Fasting Alters Cytochrome P450–Mediated Drug Metabolism in Humans , 2015, Drug Metabolism and Disposition.

[7]  I. Yano,et al.  Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin. , 2014, Biological & pharmaceutical bulletin.

[8]  V. Leandro-Merhi,et al.  Determinants of Malnutrition and Post-operative Complications in Hospitalized Surgical Patients , 2014, Journal of health, population, and nutrition.

[9]  K. Takeda,et al.  Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake , 2014, Journal of Thrombosis and Thrombolysis.

[10]  S. C. Nah,et al.  The effects of fasting in Muslim patients taking warfarin , 2014, Journal of thrombosis and haemostasis : JTH.

[11]  F. Rosendaal,et al.  Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy , 2010, British journal of haematology.

[12]  S. Hennessy,et al.  Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal Bleeding , 2008, Clinical pharmacology and therapeutics.

[13]  F. Kamali,et al.  Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot study , 2008, Journal of thrombosis and haemostasis : JTH.

[14]  E N Jonsson,et al.  A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy , 2007, Clinical pharmacology and therapeutics.

[15]  F. Kamali,et al.  Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. , 2007, Blood.

[16]  Julie A. Johnson,et al.  Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements , 2006, Clinical pharmacology and therapeutics.

[17]  Peter Wood,et al.  The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. , 2005, Blood.

[18]  J. Hambleton,et al.  The Influence of Ethnicity on Warfarin Dosage Requirement , 2005, The Annals of pharmacotherapy.

[19]  T. Saotome,et al.  Unusual hypersensitivity to warfarin in a critically ill patient , 2004, Journal of clinical pharmacy and therapeutics.

[20]  L. Rohde,et al.  Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. , 2004, The American journal of medicine.

[21]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[22]  H. Halkin,et al.  Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching , 2003, Clinical pharmacology and therapeutics.

[23]  J. Tredger,et al.  Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[24]  H. Halkin,et al.  Vitamin K Intake and Sensitivity to Warfarin in Patients Consuming Regular Diets , 1999, Thrombosis and Haemostasis.

[25]  J. Miners,et al.  Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. , 1998, British journal of clinical pharmacology.

[26]  U. Klotz,et al.  Influence of Diet and Nutritional Status on Drug Metabolism , 1996, Clinical pharmacokinetics.

[27]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[28]  Eaft Study Group.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.

[29]  H. Tanimura,et al.  Vitamin K concentrations in the plasma and liver of surgical patients. , 1990, The American journal of clinical nutrition.

[30]  D. Trenk,et al.  Disposition of vitamin K1 after intravenous and oral administration to subjects on phenprocoumon therapy , 1988 .

[31]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[32]  M. Shearer,et al.  The role of dietary vitamin K in the management of oral vitamin K antagonists. , 2012, Blood reviews.

[33]  H. Echizen,et al.  Pharmacogenetics of Warfarin Elimination and its Clinical Implications , 2001, Clinical pharmacokinetics.

[34]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .